Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Kanomata

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Urology Case Reports|August 4, 2021
Prostate cancer featuring a unique progression pattern: A case of prominent direct perineal invasion without definite metastasisTakato Nishino, Masaki Shimbo, Fumiyasu Endo, et al.
Breast Cancer (Tokyo, Japan)|December 27, 2024
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort studyTakeshi Ushigusa, Nami Hirakawa, Yuka Kajiura, et al.
Case Reports in Gastroenterology|August 11, 2022
Three Types of Subepithelial Lesion-Like Gastric Cancer Including a New Entity of Gastric AdenocarcinomaKazuki Yamamoto, Takashi Ikeya, Naoki Kanomata, et al.
Japanese Journal of Radiology|January 3, 2019
Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese menAyumu Kido, Tsutomu Tamada, Naoki Kanomata, et al.
Plos One|May 11, 2017
Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissueNaoki Kanomata, Shiro Matsuura, Tsunehisa Nomura, et al.
Breast Cancer (Tokyo, Japan)|December 12, 2019
Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cellsEmi Kishino, Ryohei Ogata, Wataru Saitoh, et al.
Breast Cancer (Tokyo, Japan)|June 11, 2013
Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumabJunichi Kurebayashi, Naoki Kanomata, Tetsumasa Yamashita, et al.
The Tohoku Journal of Experimental Medicine|October 24, 2017
Vasohibin-1 Is a Poor Prognostic Factor of Ovarian CarcinomaRikiya Sano, Naoki Kanomata, Soichiro Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2012
[Growing teratoma syndrome of the lung secondary to non-seminomatous germ cell tumor of the testis-a case report]Tomoko Yamagishi, Katsuhiko Shimizu, Masao Nakata, et al.
BMC Cancer|October 2, 2020
Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesionsToshiaki Akahane, Naoki Kanomata, Oi Harada, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Urology Case Reports|August 4, 2021
Prostate cancer featuring a unique progression pattern: A case of prominent direct perineal invasion without definite metastasisTakato Nishino, Masaki Shimbo, Fumiyasu Endo, et al.
Breast Cancer (Tokyo, Japan)|December 27, 2024
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort studyTakeshi Ushigusa, Nami Hirakawa, Yuka Kajiura, et al.
Case Reports in Gastroenterology|August 11, 2022
Three Types of Subepithelial Lesion-Like Gastric Cancer Including a New Entity of Gastric AdenocarcinomaKazuki Yamamoto, Takashi Ikeya, Naoki Kanomata, et al.
Japanese Journal of Radiology|January 3, 2019
Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese menAyumu Kido, Tsutomu Tamada, Naoki Kanomata, et al.
Plos One|May 11, 2017
Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissueNaoki Kanomata, Shiro Matsuura, Tsunehisa Nomura, et al.
Breast Cancer (Tokyo, Japan)|December 12, 2019
Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cellsEmi Kishino, Ryohei Ogata, Wataru Saitoh, et al.
Breast Cancer (Tokyo, Japan)|June 11, 2013
Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumabJunichi Kurebayashi, Naoki Kanomata, Tetsumasa Yamashita, et al.
The Tohoku Journal of Experimental Medicine|October 24, 2017
Vasohibin-1 Is a Poor Prognostic Factor of Ovarian CarcinomaRikiya Sano, Naoki Kanomata, Soichiro Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2012
[Growing teratoma syndrome of the lung secondary to non-seminomatous germ cell tumor of the testis-a case report]Tomoko Yamagishi, Katsuhiko Shimizu, Masao Nakata, et al.
BMC Cancer|October 2, 2020
Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesionsToshiaki Akahane, Naoki Kanomata, Oi Harada, et al.
Pageof 10